Mylan

Mylan, part of Viatris, is focused on healthcare solutions.

About Mylan

Mylan is a Healthcare company. Mylan, part of Viatris, is focused on healthcare solutions. It operates on a Direct-to-Consumer (D2C) model. Mylan has completed 8 acquisitions, including Acton Pharmaceuticals, Alaven Pharmaceutical and Geritol. Mylan offers products and services including Quality Medicines. Its focus areas include Pharmaceuticals and Generic Drugs.

Company details

Mylan, now integrated into Viatris, is dedicated to providing access to quality medicines. The company operates in the global healthcare sector, aiming to empower individuals to live healthier lives at every stage. Solutions are developed to ensure patients receive necessary medications when and where needed.

Key Metrics

Products & Services of Mylan

Mylan offers a comprehensive portfolio of products and services, including Quality Medicines.

Quality Medicines
Healthcare

Medicines are provided to improve patient health globally.

People of Mylan

27 people are tracked at Mylan (18 in leadership, 3 in board & advisors, 6 in team).

NameRoleGroup
Paul Campbell
Chief Accounting Officer & Corporate ControllerLeadership
Scott A. Smith
CEOLeadership
Anil Amin
Chief Business Development OfficerLeadership
David Bayles
Chief Compliance OfficerLeadership
Abhijit Barve
Chief Medical OfficerLeadership
Rajiv Malik
PresidentLeadership
Sean Ni
President, Greater ChinaLeadership
Sanjeev Narula
CFOLeadership
Andrew Enrietti
Chief Human Relations OfficerLeadership
Tony Mauro
President, Developed MarketsLeadership
Sanjeev Sethi
COOLeadership
Jeff Nau
President, Eye Care DivisionLeadership
Drew Cuneo
President, JANZ & Emerging MarketsLeadership
William Szablewski
Head, Capital MarketsLeadership
Derek Glover
Head, QualityLeadership
Sandra Keogh
Head, Integration & Business TransformationLeadership
Dennis Fuge
VP Technical Operations USALeadership
Jeff Hostler
VP FinanceLeadership
Elisha W. Finney
DirectorBoard & advisors
Robert J. Coury
Executive ChairmanBoard & advisors

7 more people are available in the full profile.

Premium access

Complete people profiles for Mylan

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Mylan

Mylan has strategically engaged in corporate development activities, having acquired 8 companies. Notable acquisitions include Acton Pharmaceuticals, Alaven Pharmaceutical and Geritol.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Generic drugs for respiratory disorders are manufactured and commercialized.
actonpharmaceuticals.comMarlborough, United States2008Aug 2013$135M
Supplements for managing sleep quality are provided by MidNite.
midnitesleep.comBlauvelt, United States2004Dec 2012β€’β€’β€’β€’
Iron deficiency drugs are manufactured by Palafer for medical applications.
palafer.caMonteregie, Canada2017Jan 2011β€’β€’β€’β€’
Nutritional supplements are manufactured by Geritol in the United States.
geritol.comWest Windsor, United States1950Jan 2011β€’β€’β€’β€’
Tablets for mental energy are manufactured and distributed by Vivarin.
vivarin.comUnited States1995Jan 2011β€’β€’β€’β€’
Alaven Pharmaceutical was founded in 2003 for pharmaceutical development.
alavenpharm.comMarietta, United States2003Aug 2010$350M
Medicines, consumer, pet, and diagnostic products are manufactured.
medpointepharma.comSomerset, United States2002Jul 2007$800M
Branded pharmaceuticals are developed and commercialized by Viatris internationally.
viatris.comFrankfurt, Germany1998Aug 2005$928.35M
Premium access

Complete acquisition details for Mylan

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Mylan

8 dated milestones of Mylan across 8 years, from founding to its latest funding, stage changes and deals.

  1. Acquisition Acquires Viatris.
  2. Acquisition Acquires Medpointe Pharmaceuticals.
  3. Acquisition Acquires Alaven Pharmaceutical.
  4. Acquisition Acquires Vivarin.
  5. Acquisition Acquires Palafer.
  6. Acquisition Acquires Geritol.
  7. Acquisition Acquires MidNite.
  8. Acquisition Acquires Acton Pharmaceuticals.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Mylan

Mylan, now integrated into Viatris, is dedicated to providing access to quality medicines. The company operates in the global healthcare sector, aiming to empower individuals to live healthier lives at every stage. Solutions are developed to ensure patients receive necessary medications when and where needed.

Mylan offers Quality Medicines.

Mylan has made 8 acquisitions, including Acton Pharmaceuticals, Alaven Pharmaceutical, and Geritol.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available